PSNL News and Press, Personalis Inc. From 09/17/20

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, announces that the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP) has exercised its option to extend our existing contract through September 2021. The VA also issued a ne...

Number of whole genomes sequenced surpasses 87,000, targeting 100,000 by year end Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced the appointment of Kevin Dunne as its new Head of Population Genomics. Mr. Dunne bri...

I have been specializing myself in the insider topic with months of empirical research to understand the trades and their informativeness. Insiders are the high managers, directors and majority shareholders of a firm and know their company better than anyone else as they are close to the s...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate in the following upcoming investor conferences. H.C. Wainwright 22nd Annual Global Investment Conference Presenting on Wednesday, September 16 at 11 a.m. ...

Investment thesis With the recent launch of Liquid Biopsy, China expansion, machine learning platform later in the year and a slight pivot to attempting to sell population sequencing to more countries, Personalis has become an even more enticing opportunity. Developments since IPO O...

Building a genomics platform isn't easy. To gain insights into mysteries of biology, any "-omics" platform needs volumes of data that would have been impossible to obtain, let alone process, just a decade ago. But gaining access to the right biobank can make all the difference and significantly ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate in the 1-on-1 meetings at the upcoming Needham Virtual Cancer Diagnostics 1x1 Conference on Tuesday, August 18, 2020. About Personalis, Inc. Personali...

Shares of Personalis (NASDAQ: PSNL) fell nearly 14% today, after the company announced the pricing of a public offering of common stock. The genomics company will issue up to 7.56 million shares of common stock at $19 apiece. The offering could result in gross proceeds of up to $143.5 millio...

Staffing 360 Solutions (NASDAQ: STAF )   -21%  on Q2 earnings . More news on: Staffing 360 Solutions, Inc., Jumia Technologies AG, Super League Gaming, Inc., Stocks on the move, , Read more ...

Personalis (NASDAQ: PSNL ) has priced its public offering of 6,578,947 common stock at $19/share, for expected gross proceeds of $125M . More news on: Personalis, Inc., Healthcare stocks news, , Read more ...